Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2018 Financial Results

Go back to Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2018 Financial Results
JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) Delayed: 240.07 --0 (-0%)
Previous Close $240.07    52 Week High $160.00 
Open $240.07    52 Week Low $95.80 
Day High $240.07    P/E 44.62 
Day Low $240.07    EPS $5.38 
Volume 1,782